Ads by Google

Liver Cancer

Regorafenib Approved by FDA - Adds to Liver Cancer Treatment Options Currently Used

Apr 28 2017 - 10:40am
Regorafenib (Stivarga) for liver cancer treatment

Yesterday was a big day for the people looking for liver cancer treatment new options as FDA expanded the indications of Bayer's Regorafenib (Stivarga) to include the treatment of patients with liver cancer who have until now been treated with Sorafenib.

According to FDA, the treatment of liver cancer with Regorafenib (Stivarga) in this trial continued until "until disease progression or unacceptable toxicity." The approval of Regorafenib for liver

GMO Insulin Shuts Down The Pancreas In Type 2 Diabetes Escalating Patients To Type 1, But You Can Avoid It

Feb 21 2017 - 7:30pm
blood sugar check

GMO Insulin has been shown to accelerate Type 2 Diabetes to Type 1 Diabetes, a study finds.

While you may have a choice avoiding GMOs (Genetically Modified Organisms) at the supermarket, you don’t have a choice avoiding GMOs if you have Type 1 or even Type 2 diabetes.

Try spring water with a twist of lemon instead of binge drinking to save your liver

Jan 22 2017 - 7:17am
Binge drinker

Researchers say if you think that binge drinking is safer for your liver than regular heavy drinking than perhaps you should stop and think this over again.

Binge drinking is a trendy thing to take part in for college students at fraternity parties and other party goers.

FDA-Approved Hepatitis C Drug Sofosbuvir Called a "Game Changer"

Dec 7 2013 - 12:41pm

A pioneering treatment for chronic hepatitis C has been approved by the Food and Drug Administration (FDA), and it is expected to be a “game changer” in that it will be the first all-oral, interferon-free therapy to use sofosbuvir, a first-in-kind nuceotide analog inhibitor with dramatically high cure rates.

Did Steve Jobs Have a Liver Transplant?

Jun 20 2009 - 10:21am
Steve Jobs Liver Transplant

Many of the major newspapers are reporting that Steve Jobs, the chief executive of Apple Inc, received a liver transplant about two months ago. There is no confirmation of the report by either Jobs or Apple.

It is known that Jobs, 53, was diagnosed with pancreatic cancer five years ago. In January Steve Jobs handed the day-to-day reins to Tim Cook. At that time, he said he would be away from the job until the end of June.

Targeting Tumor Behavior Leads To New Liver Cancer Drugs

Jun 20 2009 - 8:27am

Ohio State University cancer researchers have used computational and genomic methods to identify possible anti-cancer agents that may block a particular kind of tumor behavior. The agents target multiple genes associated with that behavior at one time.

The researchers wanted to find agents that might reverse the gene changes associated with invasive liver cancer and perhaps stop liver tumors from spreading in the body. Such therapy could greatly improve patient survival, the researchers say.

The findings are published online in the journal Cancer.

Genetic Analysis Predicts Whether Liver Cancer Likely To Recur

Oct 27 2008 - 8:17am

Researchers are poised to unlock the genetic secrets stored in hundreds of thousands of cancer biopsy samples that are in long-term storage and previously thought to be useless for modern genetic research. With the aid of a new technique developed by Howard Hughes Medical Institute researchers, scientists can now reconstruct thousands of genes that are "shredded" into tiny pieces when tissue samples are treated with a chemical fixative and stored in wax - a protocol commonly used to preserve tissue samples indefinitely.

Liver cancer associated with good post-transplant outcomes

Sep 4 2008 - 11:57pm

Patients with liver cancer can become viable candidates for transplantation if their tumors respond to treatment, a new study suggests. This report is in the September issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). The article is available online at Wiley Interscience (

Nexavar Improves Liver Cancer Survival Rates

Jul 25 2008 - 9:03am

Nexavar drug is found to improve survival rates in liver cancer patients.

A joint team of researchers from Hospital Clinic of Barcelona and Barcelona Clinic Liver Cancer (BCLC) Group has examined 602 advanced liver cancer patients who were divided into two groups: one group was taking Nexavar - sorafenib, the second group was taking a placebo.

In 'Spontaneous' Liver Cancer, Researcher Sees a Cure

Jun 20 2007 - 5:31am

Adding more good news to last week's announcement that Nexavar (sorafenib) may be the first effective treatment for advanced liver cancer, researchers at the Lombardi Comprehensive Cancer Center at Georgetown University have uncovered a new molecular mechanism that may "spontaneously" cause liver cancer.